147 related articles for article (PubMed ID: 33486865)
1. A case of mycosis fungoides successfully treated with combination of bexarotene and mogamulizumab.
Hisamoto T; Suga H; Kawana Y; Oka T; Miyagaki T; Sugaya M; Sato S
Dermatol Ther; 2021 Mar; 34(2):e14805. PubMed ID: 33486865
[No Abstract] [Full Text] [Related]
2. The oral cavity and gastric involvement in mycosis fungoides while on systemic bexarotene therapy: A rare case report.
Bayramgürler D; Kazan D; Eruyar T; Demirkesen C; Demirbaş A
Dermatol Ther; 2022 Apr; 35(4):e15349. PubMed ID: 35103368
[No Abstract] [Full Text] [Related]
3. [Granulomatous mycosis fungoides: combination therapy with bexarotene and PUVA].
Wirtz M; Helbig D
Hautarzt; 2014 Apr; 65(4):274-6. PubMed ID: 24671704
[TBL] [Abstract][Full Text] [Related]
4. Novel Inflammatory Biomarkers in Patients with Mycosis Fungoides Treated with Bexarotene.
Tamer F; Gulekon A
J Coll Physicians Surg Pak; 2021 Jun; 31(6):716-718. PubMed ID: 34102787
[TBL] [Abstract][Full Text] [Related]
5. Treatment of mycosis fungoides with bexarotene and psoralen plus ultraviolet A.
Coors EA; Von den Driesch P
Br J Dermatol; 2005 Jun; 152(6):1379-81. PubMed ID: 15949024
[No Abstract] [Full Text] [Related]
6. Development of multiple basal cell carcinomas in mycosis fungoides treated with oral bexarotene.
Calzavara-Pinton P; Leali C; Venturini M; Sala R; Zane C
Eur J Dermatol; 2007; 17(4):341-2. PubMed ID: 17540649
[No Abstract] [Full Text] [Related]
7. Successful treatment of a folliculotropic mycosis fungoides with bexarotene and PUVA.
Krönke A; Schlaak M; Arin M; Mauch C; Kurschat P
Eur J Dermatol; 2012; 22(2):259-60. PubMed ID: 22240623
[No Abstract] [Full Text] [Related]
8. Long-term control of mycosis fungoides of the hands with topical bexarotene.
Lain T; Talpur R; Duvic M
Int J Dermatol; 2003 Mar; 42(3):238-41. PubMed ID: 12653924
[TBL] [Abstract][Full Text] [Related]
9. Treatment of mycosis fungoides with oral bexarotene combined with PUVA.
Stern DK; Lebwohl M
J Drugs Dermatol; 2002 Sep; 1(2):134-6. PubMed ID: 12847736
[TBL] [Abstract][Full Text] [Related]
10. Juvenile mycosis fungoides treated with bexarotene and PUVA.
Rodríguez-Vázquez M; García-Arpa M; González-García J
Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of CD8+ syringotropic mycosis fungoides with bexarotene and local radiotherapy.
Yamamoto H; Kambayashi Y; Tamabuchi E; Hashimoto A; Asano Y; Fujimura T
Dermatol Ther; 2022 Nov; 35(11):e15850. PubMed ID: 36137929
[No Abstract] [Full Text] [Related]
12. Follicular mycosis fungoides: successful treatment with oral bexarotene.
Shistik G; Scalf LA; Fenske N; Glass LF
J Drugs Dermatol; 2004; 3(3):301-4. PubMed ID: 15176165
[TBL] [Abstract][Full Text] [Related]
13. Treatment of mycosis fungoides with bexarotene results in remission of diffuse plane xanthomas.
Gregoriou S; Rigopoulos D; Stamou C; Nikolaou V; Kontochristopoulos G
J Cutan Med Surg; 2013; 17(1):52-4. PubMed ID: 23364151
[TBL] [Abstract][Full Text] [Related]
14. Bexarotene therapy for mycosis fungoides and Sézary syndrome.
Abbott RA; Whittaker SJ; Morris SL; Russell-Jones R; Hung T; Bashir SJ; Scarisbrick JJ
Br J Dermatol; 2009 Jun; 160(6):1299-307. PubMed ID: 19222457
[TBL] [Abstract][Full Text] [Related]
15. Follicular mycosis fungoides: variability of a rare entity.
Roeschm A; Schleyer V; Landthaler M; Vogt T
Skinmed; 2005; 4(1):12-7. PubMed ID: 15654159
[TBL] [Abstract][Full Text] [Related]
16. Mogamulizumab and bexarotene are a promising association for the treatment of advanced cutaneous T-cell lymphomas: a case series.
Teoli M; Mandel VD; Franceschini C; Saraceni PL; Cicini MP; Ardigò M
Eur Rev Med Pharmacol Sci; 2022 Nov; 26(21):8118-8128. PubMed ID: 36394762
[TBL] [Abstract][Full Text] [Related]
17. Management of refractory early-stage cutaneous T-cell lymphoma (mycosis fungoides) with a combination of oral bexarotene and psoralen plus ultraviolet bath therapy.
Huber MA; Kunzi-Rapp K; Staib G; Scharffetter-Kochanek K
J Am Acad Dermatol; 2004 Mar; 50(3):475-6. PubMed ID: 14988696
[No Abstract] [Full Text] [Related]
18. Sustained remission of treatment-resistant cutaneous T-cell lymphoma with oral bexarotene.
Mehlmauer MA
Cutis; 2004 Jun; 73(6):417-20. PubMed ID: 15224787
[TBL] [Abstract][Full Text] [Related]
19. Combination of bexarotene and psoralen-UVA therapy in a patient with Mycosis fungoides.
Michaelis S; Cozzio A; Kempf W; Graf P; Burg G; Dummer R
Dermatology; 2004; 209(1):72-4. PubMed ID: 15237276
[No Abstract] [Full Text] [Related]
20. Reversible pituitary insufficiency due to bexarotene therapy in a patient with mycosis fungoides.
Atmaca H; Islek I; Sentürk N
Pituitary; 2014 Oct; 17(5):492-3. PubMed ID: 24068455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
